Cargando…

Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine

BACKGROUND: Faster acting antidepressants and biomarkers that predict treatment response are needed to facilitate the development of more effective treatments for patients with major depressive disorders. Here, we evaluate implicitly and explicitly processed emotional faces using neuroimaging to ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furey, Maura L., Drevets, Wayne C., Szczepanik, Joanna, Khanna, Ashish, Nugent, Allison, Zarate, Carlos A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571629/ https://www.ncbi.nlm.nih.gov/pubmed/25820840 http://dx.doi.org/10.1093/ijnp/pyv028

Ejemplares similares

Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder
por: Park, Lawrence, et al.
Publicado: (2018)

Ketamine normalizes brain activity during emotionally valenced attentional processing in depression
por: Reed, Jessica L., et al.
Publicado: (2018)

Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression
por: Guo, Wei, et al.
Publicado: (2018)

Correction: Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression
por: Guo, Wei, et al.
Publicado: (2019)

The Extended Functional Neuroanatomy of Emotional Processing Biases for Masked Faces in Major Depressive Disorder
por: Victor, Teresa A., et al.
Publicado: (2012)

Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials
por: Saad, Ziad, et al.
Publicado: (2020)

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
por: Drevets, Wayne C., et al.
Publicado: (2008)

Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine
por: Wohleb, Eric S., et al.
Publicado: (2017)

Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression
por: Chen, Guang, et al.
Publicado: (2022)

Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression
por: Gilbert, Jessica R., et al.
Publicado: (2021)

How do antidepressants influence the BOLD signal in the developing brain?
por: Harris, Julia J., et al.
Publicado: (2016)

Explicit authenticity and stimulus features interact to modulate BOLD response induced by emotional speech
por: Drolet, Matthis, et al.
Publicado: (2013)

Anxiolytic and Antidepressant-Like Effects of Conyza canadensis Aqueous Extract in the Scopolamine Rat Model
por: El-Akhal, Jamila, et al.
Publicado: (2021)

Neural Correlates of Suicidal Ideation and Its Reduction in Depression
por: Ballard, Elizabeth D., et al.
Publicado: (2015)

The Functional DRD3 Ser9Gly Polymorphism (rs6280) Is Pleiotropic, Affecting Reward as Well as Movement
por: Savitz, Jonathan, et al.
Publicado: (2013)

Dishabituation of the BOLD response to speech sounds
por: Zevin, Jason D, et al.
Publicado: (2005)

Understanding the contribution of neural and physiological signal variation to the low repeatability of emotion-induced BOLD responses()
por: Lipp, I., et al.
Publicado: (2014)

Robust BOLD Responses to Faces But Not to Conditioned Threat: Challenging the Amygdala's Reputation in Human Fear and Extinction Learning
por: Visser, Renée M., et al.
Publicado: (2021)

Antidepressant and anxiolytic activity of Lavandula officinalis aerial parts hydroalcoholic extract in scopolamine-treated rats
por: Rahmati, Batool, et al.
Publicado: (2017)

Amelioration of Scopolamine-Induced Amnesic, Anxiolytic and Antidepressant Effects of Ficus benghalensis in Behavioral Experimental Models
por: Malik, Humna, et al.
Publicado: (2020)

The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials
por: Moćko, Paweł, et al.
Publicado: (2023)

Development of BOLD Response to Motion in Human Infants
por: Biagi, Laura, et al.
Publicado: (2023)

Scopolamine for Tremor
Publicado: (1909)

Scopolamine Not Hyoscine!
Publicado: (1907)

Scopolamine Hydrobromate
por: Hobbs, Arthur G.
Publicado: (1894)

Scopolamine as an Anaesthetic
Publicado: (1906)

The Effect of Mineralocorticoid and Glucocorticoid Receptor Antagonism on Autobiographical Memory Recall and Amygdala Response to Implicit Emotional Stimuli
por: Young, Kymberly D., et al.
Publicado: (2016)

Brain Regulation of Emotional Conflict Predicts Antidepressant Treatment Response for Depression
por: Fonzo, Gregory A., et al.
Publicado: (2019)

Pregabalin effects on neural response to emotional faces
por: Aupperle, Robin L., et al.
Publicado: (2012)

Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response
por: Li, Q S, et al.
Publicado: (2016)

Ketamine’s Antidepressant Efficacy is Extended for at Least Four Weeks in Subjects with a Family History of an Alcohol Use Disorder
por: Niciu, Mark J., et al.
Publicado: (2014)

Effect of CGRP and sumatriptan on the BOLD response in visual cortex
por: Asghar, Mohammad S., et al.
Publicado: (2012)

Noncanonical spike‐related BOLD responses in focal epilepsy
por: Lemieux, Louis, et al.
Publicado: (2007)

Development of BOLD signal hemodynamic responses in the human brain
por: Arichi, Tomoki, et al.
Publicado: (2012)

Catecholamine depletion in first-degree relatives of individuals with mood disorders: An [(18)F]fluorodeoxyglucose positron emission tomography study()
por: Savitz, Jonathan, et al.
Publicado: (2013)

Influence of DARPP-32 genetic variation on BOLD activation to happy faces
por: Persson, Ninni, et al.
Publicado: (2017)

Effect of wearing a face mask on fMRI BOLD contrast
por: Law, Christine S.W., et al.
Publicado: (2021)

Variance of the global signal as a pretreatment predictor of antidepressant treatment response in drug-naïve major depressive disorder
por: Zhu, Jiajia, et al.
Publicado: (2018)

Predicting Dimensional Antidepressant Response to Repetitive Transcranial Magnetic Stimulation using Pretreatment Resting-state Functional Connectivity
por: Wade, Benjamin, et al.
Publicado: (2023)

A Symposium on Scopolamin
Publicado: (1905)

Cannot write session to /tmp/vufind_sessions/sess_sd8jcho587url6hra2rctr8ag6